| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |